Companies wager high on CD38-targeting drugs for blood cancer.
- Published in:
- Nature Medicine, 2012, v. 18, n. 10, p. 1446, doi. 10.1038/nm1012-1446a
- By:
- Publication type:
- Article
Works matching DE "GENMAB A/S"
Results: 6
1
2
News in brief.
- Published in:
- Chemistry & Industry, 2007, n. 1, p. 4
- Publication type:
- Article
3
RA MARKET, SMALL BUT FIERCE.
- Published in:
- Applied Clinical Trials, 2010, v. 19, n. 3, p. 16
- Publication type:
- Article
4
Other News.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 10, p. 22
- Publication type:
- Article
5
Deal watch: J&J and Genmab deal to push forward CD38 as a blood cancer target.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 11, p. 822, doi. 10.1038/nrd3890
- By:
- Publication type:
- Article
6
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2010, v. 9, n. 1, p. 9, doi. 10.1038/nrd3088
- Publication type:
- Article